Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study.
COVID-19 Isolation Eating Scale (CIES)
COVID-19 lockdown
eating disorders
eating symptoms
psychological impact
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
27 Dec 2021
27 Dec 2021
Historique:
received:
29
10
2021
revised:
17
12
2021
accepted:
20
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
18
1
2022
Statut:
epublish
Résumé
The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography. The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES). Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient. The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable.
AIMS
OBJECTIVE
(1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography.
METHODS
METHODS
The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES).
RESULTS
RESULTS
Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient.
CONCLUSIONS
CONCLUSIONS
The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients.
Identifiants
pubmed: 35010974
pii: nu14010100
doi: 10.3390/nu14010100
pmc: PMC8746935
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondo Investigación Sanitario-FIS
ID : FIS, INT19/00046, PI17/01167
Organisme : Ministerio de Economía y Competitividad
ID : PSI2015-68701-R
Organisme : Portuguese Foundation for Science and Technology grant
ID : POCI-01-0145-FEDER-028145
Organisme : Consejo Nacional de Ciencia y Tecnología
ID : None
Organisme : Generalitat de Catalunya
ID : None
Organisme : European Regional Development Fund
ID : None
Références
Eur Eat Disord Rev. 2012 May;20(3):250-4
pubmed: 22383308
Psychol Methods. 2012 Jun;17(2):137-52
pubmed: 22545595
Eur Eat Disord Rev. 2020 Nov;28(6):826-835
pubmed: 32643844
Eat Weight Disord. 2021 Dec;26(8):2443-2452
pubmed: 33426630
Int J Eat Disord. 2020 Jul;53(7):1166-1170
pubmed: 32476175
Eur Psychiatry. 2018 Oct;54:109-116
pubmed: 30193141
J Affect Disord. 2021 Apr 15;285:77-83
pubmed: 33636674
Eat Weight Disord. 2021 Dec;26(8):2771-2777
pubmed: 33582970
Int J Eat Disord. 2020 May;53(5):369-376
pubmed: 32338400
Psychiatry Res. 2020 May;287:112934
pubmed: 32229390
Int J Eat Disord. 2021 Jul;54(7):1213-1223
pubmed: 33885180
Eur Eat Disord Rev. 2020 Nov;28(6):855-863
pubmed: 32815293
Int J Eat Disord. 2020 Nov;53(11):1791-1800
pubmed: 32841413
J Behav Addict. 2020 Apr 29;9(2):184-186
pubmed: 32352927
J Eat Disord. 2021 Jan 12;9(1):10
pubmed: 33436064
Eat Weight Disord. 2021 Apr;26(3):747-750
pubmed: 32488728
J Eat Disord. 2020 Nov 2;8(1):57
pubmed: 33292539
Int J Eat Disord. 2020 Nov;53(11):1855-1862
pubmed: 32856333
Nutrients. 2021 Mar 10;13(3):
pubmed: 33801989
Eur Eat Disord Rev. 2020 May;28(3):239-245
pubmed: 32346977
J Eat Disord. 2020 Aug 31;8:44
pubmed: 32874585
Eur Eat Disord Rev. 2020 Nov;28(6):847-854
pubmed: 32767858
Int J Eat Disord. 2020 Nov;53(11):1780-1790
pubmed: 32720399
Eur J Clin Nutr. 2013 Sep;67(9):944-9
pubmed: 23695203
Eur Eat Disord Rev. 2020 Nov;28(6):871-883
pubmed: 32954595
Nutrients. 2020 May 28;12(6):
pubmed: 32481594
Cad Saude Publica. 2020 Apr 30;36(4):e00054020
pubmed: 32374806
Neuropsychiatr. 2021 Jun;35(2):57-67
pubmed: 32346850
JAMA Psychiatry. 2020 Sep 1;77(9):974-976
pubmed: 32352480
Singapore Med J. 2020 Jul;61(7):350-356
pubmed: 32241071
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
J Eat Disord. 2020 Apr 20;8:19
pubmed: 32337045
J Addict Med. 2020 Jul/Aug;14(4):e10-e12
pubmed: 32433365
Obesity (Silver Spring). 2020 Sep;28(9):1576-1577
pubmed: 32428295
J Pers Soc Psychol. 2007 Sep;93(3):478-90
pubmed: 17723061
Disaster Med Public Health Prep. 2020 Jul 14;:1-6
pubmed: 32660669
Eur Eat Disord Rev. 2019 Jul;27(4):410-420
pubmed: 31020776
Int J Eat Disord. 2020 Jul;53(7):1158-1165
pubmed: 32476163
Eat Weight Disord. 2021 Oct;26(7):2287-2300
pubmed: 33387275